# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA621422 | F | Inhibitor activity against A549 (Human lung carcinoma)cell line with varying concentration of the drug for 72 hrs | Homo sapiens | 6 | ALA1129274 | cell-based format | Scientific Literature | |
2. | ALA641185 | F | Compound was tested for the inhibition of AMML (acute myelomonocytic leukemia) | Homo sapiens | 4 | ALA1123247 | cell-based format | Scientific Literature | |
3. | ALA659398 | F | Compound was tested for the inhibition of CML/BC(chronic myeloid leukemia, blast crisis) | Homo sapiens | 3 | ALA1123247 | cell-based format | Scientific Literature | |
4. | ALA681014 | F | Compound was tested for the inhibition of glioblastoma | Homo sapiens | 4 | ALA1123247 | cell-based format | Scientific Literature | |
5. | ALA695272 | F | Compound was tested for the inhibition of human HL60 Leukemia | Homo sapiens | 4 | ALA1123247 | cell-based format | Scientific Literature | |
6. | ALA695113 | F | Inhibitor activity against HT-29 (Human colon carcinoma)cell line with varying concentration of the drug for 72 hrs | Homo sapiens | 5 | ALA1129274 | cell-based format | Scientific Literature | |
7. | ALA702188 | F | Antitumor activity was determined against the ip implanted L1210 leukemia in mice by range in survival days at 5 mg/kg (treatment of 1-5qd schedule) dosage; Range is 8-9 | Mus musculus | 1 | ALA1123247 | organism-based format | Scientific Literature | |
8. | ALA708743 | F | Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent increase in life span at 5 mg/kg (treatment of 1-5qd schedule) dosage | Mus musculus | 1 | ALA1123247 | organism-based format | Scientific Literature | |
9. | ALA707474 | F | Antitumor activity was determined against the ip implanted L1210 leukemia in mice by 45-day survivors in mice at 5 mg/kg (treatment of 1-5qd schedule) dosage | Mus musculus | 1 | ALA1123247 | organism-based format | Scientific Literature | |
10. | ALA708749 | F | Antitumor activity was determined against the ip implanted L1210 leukemia in mice by percent median survival rate (treated/control) at 5 mg/kg (treatment of 1-5qd schedule) dosage; 9.0/8.0 | Mus musculus | 1 | ALA1123247 | organism-based format | Scientific Literature | |
11. | ALA701034 | F | Inhibitor activity against L1210 (murine leukemia )cell line with varying concentration of the drug for 72 hrs | Mus musculus | 5 | ALA1129274 | cell-based format | Scientific Literature | |
12. | ALA701035 | F | Inhibitor activity against L1210/vmdr (transfected with a plasmid containing mdr1) cell line with varying concentration of the drug for 72 hrs | Mus musculus | 5 | ALA1129274 | cell-based format | Scientific Literature | |
13. | ALA702617 | F | Antitumor activity against the ip implanted L1210 leukemia in mice expressed as optimal dose (1-5qd treatment schedule) required to produce greatest increase in life span was determined | Mus musculus | 8 | ALA1123247 | organism-based format | Scientific Literature | |
14. | ALA714308 | F | Inhibitor activity against Lewis lung (murine lung carcinoma)cell line with varying concentration of the drug for 72 hrs | Mus musculus | 3 | ALA1129274 | cell-based format | Scientific Literature | |
15. | ALA708917 | F | Inhibitor activity against MCF-7(Human breast carcinoma)cell line with varying concentration of the drug for 72 hrs | Homo sapiens | 6 | ALA1129274 | cell-based format | Scientific Literature | |
16. | ALA708918 | F | Inhibitor activity against MCF-7/Adr (Human colon carcinoma)cell line with varying concentration of the drug for 72 hrs | Homo sapiens | 6 | ALA1129274 | cell-based format | Scientific Literature | |
17. | ALA750633 | F | Compound was tested for the inhibition of non- small cell lung cancer | Homo sapiens | 1 | ALA1123247 | cell-based format | Scientific Literature | |
18. | ALA759003 | F | Inhibitor activity against P388 (murine leukemia )cell line with varying concentration of the drug for 72 hrs | Mus musculus | 3 | ALA1129274 | cell-based format | Scientific Literature | |
19. | ALA759004 | F | Inhibitor activity against P388/Adr (murine leukemia )cell line with varying concentration of the drug for 72 hrs | Mus musculus | 3 | ALA1129274 | cell-based format | Scientific Literature | |
20. | ALA805566 | F | Compound was tested for the inhibition of small cell lung cancer | Homo sapiens | 4 | ALA1123247 | cell-based format | Scientific Literature |